Pediatrix Medical Group, Inc.
US ˙ NYSE ˙ US58502B1061

SecurityMD / Pediatrix Medical Group, Inc.
InstitutionAperio Group, LLC
Latest Disclosed Ownership91,547 shares
Latest Disclosed Value $ 2,247,000
Aperio Group, LLC reports 2.06% decrease in ownership of MD / Pediatrix Medical Group, Inc.

On February 5, 2021 - Aperio Group, LLC filed a 13F-HR form disclosing ownership of 91,547 shares of Pediatrix Medical Group, Inc. (US:MD) valued at $2,246,563 USD as of December 31, 2020. The entity filed a previous 13F-HR on November 6, 2020 disclosing 93,470 shares of Pediatrix Medical Group, Inc.. This represents a change in shares of -2.06% during the quarter. The current value of the position is $2,069,878 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2021-02-05 2020-12-31 13F MEDNAX COM 58502B106 91,547 -1,923 -2.06 2,247 47.63 0.0066
2020-11-06 2020-09-30 13F MEDNAX COM 58502B106 93,470 579 0.62 1,522 -4.16 0.0051
2020-08-13 2020-06-30 13F MEDNAX COM 58502B106 92,891 4,487 5.08 1,588 54.32 0.0059
2020-05-05 2020-03-31 13F MEDNAX COM 58502B106 88,404 -25,979 -22.71 1,029 -67.63 0.0045
2020-02-13 2019-12-31 13F MEDNAX COM 58502B106 114,383 24,126 26.73 3,179 55.76 0.0114
2019-11-06 2019-09-30 13F MEDNAX COM 58502B106 90,257 -14,178 -13.58 2,041 -22.54 0.0081
2019-07-30 2019-06-30 13F MEDNAX COM 58502B106 104,435 42,838 69.55 2,635 57.41 0.0108
2019-05-13 2019-03-31 13F MEDNAX COM 58502B106 61,597 2,717 4.61 1,674 -13.89 0.0072
2019-05-06 2018-12-31 13F/A-1 MEDNAX COM 58502B106 58,880 6,011 11.37 1,944 -21.17 0.0098
2019-02-14 2018-12-31 13F MEDNAX COM 58502B106 58,866 5,997 1,943
2019-05-06 2018-09-30 13F/A-1 MEDNAX COM 58502B106 52,869 -3,808 -6.72 2,466 0.53 0.0109
2018-10-17 2018-09-30 13F MEDNAX INC COM COMMON 58502B106 52,869 -3,808 2,467
2019-05-06 2018-06-30 13F/A-1 MEDNAX COM 58502B106 56,677 -2,031 -3.46 2,453 -24.89 0.0117
2018-07-30 2018-06-30 13F MEDNAX INC COM COMMON 58502B106 56,677 -2,031 2,453
2019-05-01 2018-03-31 13F/A-1 MEDNAX COM 58502B106 58,708 -269 -0.46 3,266 3.62 0.0163
2018-05-08 2018-03-31 13F MEDNAX INC COM COMMON 58502B106 58,708 -269 3,266
2019-05-01 2017-12-31 13F/A-1 MEDNAX COM 58502B106 58,977 17,289 41.47 3,152 75.31 0.0163
2018-02-02 2017-12-31 13F MEDNAX INC COM COMMON 58502B106 58,977 17,289 3,152
2019-05-01 2017-09-30 13F/A-1 MEDNAX COM 58502B106 41,688 18,012 76.08 1,798 25.82 0.0102
2017-10-25 2017-09-30 13F MEDNAX INC COM COMMON 58502B106 41,688 18,012 1,798
2019-04-22 2017-06-30 13F/A-1 MEDNAX COM 58502B106 23,676 -1,329 -5.31 1,429 -17.59 0.0088
2017-07-18 2017-06-30 13F MEDNAX INC COM COMMON 58502B106 23,676 -1,329 1,429
2019-04-22 2017-03-31 13F/A-1 MEDNAX COM 58502B106 25,005 5,394 27.50 1,734 32.67 0.0119
2017-05-05 2017-03-31 13F MEDNAX INC COM COMMON 58502B106 25,005 5,394 1,735
2019-04-22 2016-12-31 13F/A-1 MEDNAX COM 58502B106 19,611 -2,807 -12.52 1,307 -11.99 0.0100
2017-02-14 2016-12-31 13F MEDNAX INC COM COMMON 58502B106 19,611 -2,807 1,307
2019-04-12 2016-09-30 13F/A-1 MEDNAX COM 58502B106 22,418 4,085 22.28 1,485 11.82 0.0108
2016-11-01 2016-09-30 13F MEDNAX INC COM COMMON 58502B106 22,418 4,085 1,485
2019-04-12 2016-06-30 13F/A-1 MEDNAX COM 58502B106 18,333 -639 -3.37 1,328 8.41 0.0104
2016-08-12 2016-06-30 13F MEDNAX INC COM COMMON 58502B106 18,333 -639 1,328
2019-04-12 2016-03-31 13F/A-1 MEDNAX COM 58502B106 18,972 3,136 19.80 1,225 7.93 0.0105
2016-04-28 2016-03-31 13F MEDNAX INC COM COMMON 58502B106 18,972 3,136 1,226
2016-01-21 2015-12-31 13F MEDNAX INC COM COMMON 58502B106 15,836 1,248 8.55 1,135 1.34 0.0104
2015-10-19 2015-09-30 13F MEDNAX INC COM COMMON 58502B106 14,588 957 7.02 1,120 10.89 0.0114
2015-07-29 2015-06-30 13F MEDNAX INC COM COMMON 58502B106 13,631 3,759 38.08 1,010 41.06 0.0104
2015-04-29 2015-03-31 13F MEDNAX INC COM COMMON 58502B106 9,872 9,872 0.00 716 0.0080
2015-01-30 2014-12-31 13F MEDNAX INC COM COMMON 58502B106 0 -8,845 -100.00 0 -100.00
2014-10-21 2014-09-30 13F MEDNAX INC COM COMMON 58502B106 8,845 753 9.31 485 2.97 0.0066
2014-07-23 2014-06-30 13F MEDNAX INC COM COMMON 58502B106 8,092 222 2.82 471 -3.48 0.0068
2014-04-25 2014-03-31 13F MEDNAX INC COM COMMON 58502B106 7,870 488 23.86 0.0069
2014-01-30 2013-12-31 13F MEDNAX INC COM COMMON 58502B106 394 18.32 0.0061
2013-10-24 2013-09-30 13F MEDNAX INC COM COMMON 58502B106 3,321 457 15.96 333 27.10 0.0064
2013-07-19 2013-06-30 13F MEDNAX INC COM COMMON 58502B106 2,864 262
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.